| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Purchase of right of first refusal agreement | 0 | NaN | NaN | NaN |
| Issuance of common stock for compensation | NaN | 0 | 0 | 0 |
| Net cash used in investing activities | 0 | NaN | NaN | NaN |
| Note default penalties and interest | NaN | NaN | 0 | 306,323 |
| Issuance of common stock for accrued compensation | NaN | 0 | 0 | 10,000 |
| Proceeds from loans, related party | NaN | 3,600 | NaN | NaN |
| Proceeds from notes payable to related party | 5,000 | NaN | NaN | NaN |
| Loss on conversion of notes payable | NaN | -4,464 | 0 | 232,220 |
| Net cash provided by financing activities | 5,000 | 3,600 | NaN | 0 |
| Amortization of right of first refusal agreement cost | 0 | 0 | 0 | 0 |
| Issuance of common stock for compensation | 0 | NaN | NaN | NaN |
| Issuance of common stock for debt conversion | 0 | 80,776 | NaN | NaN |
| Issuance of series b preferred stock for accrued compensation | NaN | 20,000 | NaN | NaN |
| Accrued interest | 0 | 1 | -1,314 | 886 |
| Accounts payable | -1,000 | -335 | 2,056 | -1,251 |
| Accrued officers compensation | 30,000 | 10,000 | 30,000 | 20,000 |
| Net income (loss) | -33,376 | 337,757 | -36,099 | -390,853 |
| Net cash used in operating activities | -4,376 | -24,140 | -5,357 | -19,501 |
| Net increase (decrease) in cash | 624 | NaN | NaN | NaN |
| Purchase of right of first refusal agreement | 0 | NaN | NaN | NaN |
| Net cash used in investing activities | 0 | NaN | NaN | 0 |
| Net increase (decrease) in cash | 624 | -20,540 | -5,357 | -19,501 |
| Cash balance, beginning of period | 815 | 21,355 | 57,368 | NaN |
| Cash balance, end of period | 1,439 | 815 | 21,355 | NaN |
Greater Cannabis Company, Inc. (GCAN)
Greater Cannabis Company, Inc. (GCAN)